Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$19.94
0.251.27%
Last update: Oct 5, 5:53 AM
$20.15
0.462.34%
BlossomHill Therapeutics Inc (BLSM) Stock Price, Quote, News & History
BLSMNASDAQ
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
BlossomHill Therapeutics Inc is a clinical-stage biopharmaceutical company applying its intentional, chemistry-based approach to develop small molecule medicines that address unmet medical needs in cancer treatment. Its product pipeline includes two...
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of BlossomHill Therapeutics (NASDAQ:BLSM) through any online brokerage.
Other companies in BlossomHill Therapeutics’s space includes: Eli Lilly and Co (NYSE:LLY), Johnson & Johnson (NYSE:JNJ), Merck & Co Inc (NYSE:MRK), Novartis AG (NYSE:NVS) and AstraZeneca PLC (NYSE:AZN).
BlossomHill Therapeutics has a consensus price target of $34.17.
The stock price for BlossomHill Therapeutics (NASDAQ: BLSM) is $20.15 last updated October 5, 2026 at 5:53 AM EDT.
There are no upcoming dividends for BlossomHill Therapeutics.
BlossomHill Therapeutics does not have any upcoming earnings scheduled.
There is no upcoming split for BlossomHill Therapeutics.
BlossomHill Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
